advertisement
Frontiers in cellular neuroscience 20
Showing records 1 to 20 | Display all abstracts in Frontiers in cellular neuroscience108016 Deficiency of the RNA-binding protein ELAVL1/HuR leads to the failure of endogenous and exogenous neuroprotection of retinal ganglion cells
Pacwa A
Frontiers in cellular neuroscience 2023; 17: 1131356
108736 Topical and systemic GLP-1R agonist administration both rescue retinal ganglion cells in hypertensive glaucoma
Lawrence ECN
Frontiers in cellular neuroscience 2023; 17: 1156829
108397 Posttranslational modifications of proteins in diseased retina
Starr CR
Frontiers in cellular neuroscience 2023; 17: 1150220
108540 RAGE and its ligand amyloid beta promote retinal ganglion cell loss following ischemia-reperfusion injury
Seyed Hosseini Fin N
Frontiers in cellular neuroscience 2023; 17: 1156084
108397 Posttranslational modifications of proteins in diseased retina
Gorbatyuk MS
Frontiers in cellular neuroscience 2023; 17: 1150220
108540 RAGE and its ligand amyloid beta promote retinal ganglion cell loss following ischemia-reperfusion injury
Georgevsky D
Frontiers in cellular neuroscience 2023; 17: 1156084
108016 Deficiency of the RNA-binding protein ELAVL1/HuR leads to the failure of endogenous and exogenous neuroprotection of retinal ganglion cells
Machowicz J
Frontiers in cellular neuroscience 2023; 17: 1131356
108736 Topical and systemic GLP-1R agonist administration both rescue retinal ganglion cells in hypertensive glaucoma
Guo M
Frontiers in cellular neuroscience 2023; 17: 1156829
108540 RAGE and its ligand amyloid beta promote retinal ganglion cell loss following ischemia-reperfusion injury
Sukkar MB
Frontiers in cellular neuroscience 2023; 17: 1156084
108736 Topical and systemic GLP-1R agonist administration both rescue retinal ganglion cells in hypertensive glaucoma
Schwartz TD
Frontiers in cellular neuroscience 2023; 17: 1156829
108016 Deficiency of the RNA-binding protein ELAVL1/HuR leads to the failure of endogenous and exogenous neuroprotection of retinal ganglion cells
Akhtar S
Frontiers in cellular neuroscience 2023; 17: 1131356
108736 Topical and systemic GLP-1R agonist administration both rescue retinal ganglion cells in hypertensive glaucoma
Wu J
Frontiers in cellular neuroscience 2023; 17: 1156829
108540 RAGE and its ligand amyloid beta promote retinal ganglion cell loss following ischemia-reperfusion injury
Golzan SM
Frontiers in cellular neuroscience 2023; 17: 1156084
108016 Deficiency of the RNA-binding protein ELAVL1/HuR leads to the failure of endogenous and exogenous neuroprotection of retinal ganglion cells
Rodak P
Frontiers in cellular neuroscience 2023; 17: 1131356
108736 Topical and systemic GLP-1R agonist administration both rescue retinal ganglion cells in hypertensive glaucoma
Lu J
Frontiers in cellular neuroscience 2023; 17: 1156829
108016 Deficiency of the RNA-binding protein ELAVL1/HuR leads to the failure of endogenous and exogenous neuroprotection of retinal ganglion cells
Liu X; Pietrucha-Dutczak M
Frontiers in cellular neuroscience 2023; 17: 1131356
108736 Topical and systemic GLP-1R agonist administration both rescue retinal ganglion cells in hypertensive glaucoma
Nikonov S
Frontiers in cellular neuroscience 2023; 17: 1156829
108016 Deficiency of the RNA-binding protein ELAVL1/HuR leads to the failure of endogenous and exogenous neuroprotection of retinal ganglion cells
Lewin-Kowalik J
Frontiers in cellular neuroscience 2023; 17: 1131356
108736 Topical and systemic GLP-1R agonist administration both rescue retinal ganglion cells in hypertensive glaucoma
Sterling JK; Cui QN
Frontiers in cellular neuroscience 2023; 17: 1156829
108016 Deficiency of the RNA-binding protein ELAVL1/HuR leads to the failure of endogenous and exogenous neuroprotection of retinal ganglion cells
Amadio M; Smedowski A
Frontiers in cellular neuroscience 2023; 17: 1131356
